JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Michael Weyand
Frank Harig
Teddy Fischlein
Stephan M. Ensminger
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abele, S.
Right arrow Articles by Ensminger, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abele, S.
Right arrow Articles by Ensminger, S. M.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Transplantation - heart

J Thorac Cardiovasc Surg 2006;131:1161-1166
© 2006 The American Association for Thoracic Surgery


Cardiothoracic Transplantation

Clopidogrel reduces the development of transplant arteriosclerosis

Silke Abele a , Michael Weyand, MD a , Martina Wollin a , b , Nicola E. Hiemann, MD c , Frank Harig, MD a , Teddy Fischlein, MD a , Stephan M. Ensminger, MD, DPhil a , *

a Department of Cardiac Surgery, Institute for Clinical Immunology, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen, Germany
b Department of Medicine III, Institute for Clinical Immunology, Friedrich-Alexander University Erlangen-Nuernberg, Erlangen, Germany
c Department of Cardiothoracic Surgery, Deutsches Herzzentrum, Berlin, Germany

Received for publication September 20, 2005; revisions received December 6, 2005; accepted for publication January 13, 2006.

* Address for reprints: Stephan M. Ensminger, MD, DPhil, Department of Cardiac Surgery, Friedrich-Alexander University Erlangen-Nuernberg, Krankenhausstrasse 12, 91054 Erlangen, Germany (Email: stephan.ensminger{at}herz.imed.uni-erlangen.de).

BACKGROUND: Transplant arteriosclerosis, the hallmark feature of chronic rejection, is still the major limiting factor for the long-term success of heart transplantation. Platelets have been implicated to play a role in the pathogenesis of this disease. Therefore the aim of this study was to investigate whether platelet inhibition alone has a positive effect on the development of transplant arteriosclerosis.

METHODS: Fully major histocompatibility complex–mismatched C57BL/6 (H2b) donor aortas were transplanted into CBA (H2k) recipients, and mice received different doses (1, 10, and 20 mg/kg) of clopidogrel or control saline as a daily intraperitoneal injection for 30 days. Blood was analyzed on days 2, 7, 14, and 30 by using a platelet aggregation test (adenosine diphosphate) for effectiveness of the treatment. Grafts were analyzed by means of histology and morphometry on day 30 after transplantation.

RESULTS: When mice were treated daily with 1 mg/kg clopidogrel in the absence of any other immunosuppression, transplant arteriosclerosis was significantly reduced compared with that seen in saline-treated control animals (intimal proliferation of 66% ± 9% [1 mg/kg clopidogrel] vs 77% ± 5% [control], n = 7, P ≤ .03). Daily application of 10 mg/kg and 20 mg/kg clopidogrel also significantly reduced the development of transplant arteriosclerosis compared with that seen in control animals (intimal proliferation of 61% ± 11% [10 mg/kg clopidogrel] vs 54% ± 10% [20 mg/kg clopidogrel] vs 77% ± 5% [control], n = 8, P ≤ .003). There was, however, no additional beneficial effect when compared with mice treated with 1 mg/kg clopidogrel (P = .06). Isografts did not show any signs of vascular lesions on day 30 after transplantation.

CONCLUSION: These results demonstrate that monotherapy with clopidogrel can effectively reduce the formation of transplant arteriosclerosis in a murine aortic allograft model.



Abbreviations and Acronyms ADP = adenosine diphosphate; CD40L = CD40 ligand; PDGF = platelet-derived growth factor





This article has been cited by other articles:


Home page
Circ. Res.Home page
R. N. Mitchell and P. Libby
Vascular Remodeling in Transplant Vasculopathy
Circ. Res., April 13, 2007; 100(7): 967 - 978.
[Abstract] [Full Text] [PDF]


Home page
VASC ENDOVASCULAR SURGHome page
Chia Shu Hui, C. S. McLachlan, and M. Moursi
Can Clopidogrel Monotherapy Influence Vascular Remodeling?
Vascular and Endovascular Surgery, April 1, 2007; 41(2): 165 - 166.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The American Association for Thoracic Surgery.